-+ 0.00%
-+ 0.00%
-+ 0.00%

Aquestive Therapeutics holds annual shareholder meeting

PUBT·06/10/2026 20:03:06
Listen to the news
Aquestive Therapeutics holds annual shareholder meeting
  • At its June 10, 2026 annual meeting, Aquestive Therapeutics’ shareholders backed the board’s Class II director nominees for three-year terms through 2029.
  • Shareholders also ratified KPMG as independent registered public accounting firm for fiscal 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001398733-26-000033), on June 10, 2026, and is solely responsible for the information contained therein.